Fidelity Investments’s Pulse Biosciences PLSE Stock Holding History
Bought
Maintained
Sold
Other funds holding PLSE
Fidelity Investments's PLSE Position: Q3 2026 in Review
Fidelity Investments increased its Pulse Biosciences (PLSE) stake by 3.6% in Q3 2026, buying an estimated $21K and bringing the position to 14,445 shares worth $721K. The position accounts for ﹤0.01% of the portfolio, ranked #3158.
Fidelity Investments first reported a position in PLSE in Q1 2022 and has held it in 16 quarters since. 53 funds tracked by Wall St. Rank hold PLSE as of Q3 2026.
- Fidelity Investments held 14,445 shares of Pulse Biosciences worth $721K as of Q3 2026.
- Fidelity Investments bought 497 Pulse Biosciences shares in Q3 2026, an estimated $21K.
- Pulse Biosciences made up ﹤0.01% of Fidelity Investments's portfolio in Q3 2026, its #3158 holding.
- Fidelity Investments first reported a position in Pulse Biosciences in Q1 2022 and has held it in 16 quarters since.
- 53 funds tracked by Wall St. Rank held Pulse Biosciences as of Q3 2026.
Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.